Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/32477
Title: Multicenter Analysis of Anidulafungin Use in Invasive Candida Infections
Authors: Isikgoz Tasbakan, M
Eren Kutsoylu, O
Pullukcu, H
Sayin Kutlu, S
Ozturk, B
Kaya, O
Turhan, O
Senol Akat, Sebnem
Alp Cavus, Sema
Kutlu, Murat
Mermut, Gulsen
Metin, Dilek Yesim
Ozhak, Betil
Ergin, Cagri
Cetin, Cigdem Banu
Ertugrul, Mustafa Bulent
Avkan Oguz, Vildan
Yapar, Nur
Keywords: Candidemia; Anidulafungin; Candida species; Central venous catheters
Publisher: BILIMSEL TIP YAYINEVI
Abstract: Introduction: Fungal infections are vital problems worldwide and their incidence have increased along with changing patient profile. Particularly candida species is still the most commonfungal agent, and the significance of non-albicans candida species have gained importance in recent years. In the present study, it was aimed to evaluate retrospectively the risk factors and distribution of candida species in patients with invasive candida infections, who were treated with anidulafungin.
Materials and Methods: In the first three years (1 January 2012 to 31 December 2014) when anidulafungin came out in our country, we retrospectively evaluated the data of the patients with invasive candida infections who were treated by anidulafungin for more than 48 hours in seven university hospitals. Data were recorded to the case report forms.
Results: Two hundreds and fifty-seven patients were included into the study. Fifty-six percent of the patients were male and mean age was 58.57 +/- 19.5 years. Two hundreds and three patients (79%) were hospitalized in intensive care units, 37 (14.3%) in internal medicine services, and 17 (0.07%) in surgery services. As previously described, we detected antibiotic usage in the last month (%96.9), presence of urinary catheter (90.3%) and presence of central venous catheter (82.1%) as risk factors for invasive candida infections. More than half of the patients (57.1%) with central venous catheter had candidemia. Sixty-six (47.7%) of the blood isolates were Candida albicans, 33 (23.7%) were Candida parapsilosis, 17 (12.2%) were Candida tropicalis and 13 (9.4%) were Candida glabrata. During follow up, 64.5% of 124 patients whose catheters couldn't be taken off and 47.6% of 86 patients whose catheters could be taken off died. During anidulafungin treatment, one anaphylaxis, one skin eruption and one thrombocytopenia were seen as side effects.
Conclusion: In our study, we found that removal of central venous catheter of the patients with candidemia was a positive effect on mortality. We suggest that patients with candidemia, insisting on catheter removal besides antifungal treatment is necessary. We observed that anidulafungin is an effective and safe choice in invasive candida infections.
URI: https://hdl.handle.net/11499/32477
https://doi.org/10.5578/flora.67777
Appears in Collections:Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
Çağrı Ergin.pdf212.96 kBAdobe PDFView/Open
Show full item record



CORE Recommender

Page view(s)

60
checked on Aug 24, 2024

Download(s)

28
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.